Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Corbus Pharmaceuticals Holdings Inc. (CRBP)

5.08   0.16 (3.25%) 12-12 16:00
Open: 4.91 Pre. Close: 4.92
High: 5.08 Low: 4.8944
Volume: 387,124 Market Cap: 329M
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.966 - 4.987 4.987 - 5.006
Low: 4.77 - 4.792 4.792 - 4.814
Close: 4.884 - 4.919 4.919 - 4.952

Technical analysis

as of: 2019-12-12 3:59:21 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 6.13     One year: 7.16
Support: Support1: 4.59    Support2: 4.18
Resistance: Resistance1: 5.25    Resistance2: 6.13
Pivot: 4.82
Moving Average: MA(5): 4.98     MA(20): 4.72
MA(100): 5.18     MA(250): 6.32
MACD: MACD(12,26): 0.05     Signal(9):
Stochastic oscillator: %K(14,3): 65.61     %D(3): 65.27
RSI: RSI(14): 57.68
52-week: High: 9.11  Low: 4.18  Change(%): -22.1
Average Vol(K): 3-Month: 59766  10-Days: 48560

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CRBP has closed below upper band by 14.9%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) Crispr Therapeutics AG (NASDAQ: CRSP ) Diplomat Pharmacy Inc (NYSE: DPLO )( warned of going concern risk) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) DexCom, Inc. (NASDAQ: DXCM ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Galera Therapeutics Inc (NASDAQ: GRTX ) Insulet Corporation (NASDAQ: PODD ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) XOMA Corp (NASDAQ: XOMA ) Zai Lab Ltd (NASDAQ: ZLAB ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov.

Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
- Presentation with live audio webcast on Wednesday, November 20th at 5:20 PM DST - Norwood, MA , Nov. 12, 2019 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP).

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64.67
Shares Float (M) 56.12
% Held by Insiders 5.45
% Held by Institutions 44.44
Shares Short (K) 16370
Shares Short P. Month (K)

Stock Financials

Book Value (p.s.) 0.460
PEG Ratio
Profit Margin -175.17
Operating Margin -190.17
Return on Assets (ttm) -65.3
Return on Equity (ttm) -171.5
Qtrly Rev. Growth 137.4
Gross Profit (p.s.) -0.677
Sales Per Share
EBITDA (p.s.) -1.034
Qtrly Earnings Growth
Operating Cash Flow (M) -37.22
Levered Free Cash Flow (M) -18.74

Stock Valuations

P/E -5.07
P/E Growth Ratio 0.03
P/BV 11.03
P/S 8.90
P/CF -8.82

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.